Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
Thornhill JP. et al, (2019), Mucosal Immunology, 12, 1212 - 1219
Development of a Simple In Vitro Assay to Assess Digestion of the Extracellular Matrix of the Human Pancreas by Collagenase Enzyme Blends
Spiers RM. et al, (2018), Cell Transplantation, 27, 1039 - 1046
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
Martin GE. et al, (2018), Frontiers in Immunology, 9
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Hoffmann M. et al, (2016), PLOS Pathogens, 12, e1005661 - e1005661
Structured Observations Reveal Slow HIV-1 CTL Escape
Roberts HE. et al, (2015), PLOS Genetics, 11, e1004914 - e1004914
HIV-1 DNA predicts disease progression and post-treatment virological control
Williams JP. et al, (2014), eLife, 3
HIV-1-specific CD4 + responses in primary HIV-1 infection predict disease progression
Frater J. et al, (2014), AIDS, 28, 699 - 708
Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection
Yager N. et al, (2013), AIDS, 27, 313 - 323
Failure to Detect Xenotropic Murine Leukemia Virus–Related Virus in Blood of Individuals at High Risk of Blood‐Borne Viral Infections
Barnes E. et al, (2010), The Journal of Infectious Diseases, 202, 1482 - 1485
Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa
Huang K-HG. et al, (2009), Antiviral Therapy, 14, 975 - 984
Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression
Frater AJ. et al, (2007), Journal of Virology, 81, 6742 - 6751
CD8+T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef
Milicic A. et al, (2005), The Journal of Immunology, 175, 4618 - 4626
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
Scriba TJ. et al, (2005), The Journal of clinical investigation, 115, 443 - 450
HIV-1–specific CD4+ T lymphocyte turnover and activation increase upon viral rebound
Scriba TJ. et al, (2005), Journal of Clinical Investigation, 115, 443 - 450